4//SEC Filing
Ferrara Robert L 4
Accession 0001209191-22-059702
CIK 0001533040other
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 4:30 PM ET
Size
5.2 KB
Accession
0001209191-22-059702
Insider Transaction Report
Form 4
Ferrara Robert L
Director
Transactions
- Purchase
Common stock, $0.0001 par value
2022-12-02$0.41/sh+5,000$2,041→ 30,000 total
Footnotes (2)
- [F1]This transaction was executed in multiple trades at prices ranging from $0.4075 to $0.4089. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]Includes shares of common stock underlying unvested restricted stock units.
Documents
Issuer
Phio Pharmaceuticals Corp.
CIK 0001533040
Entity typeother
Related Parties
1- filerCIK 0001792987
Filing Metadata
- Form type
- 4
- Filed
- Dec 4, 7:00 PM ET
- Accepted
- Dec 5, 4:30 PM ET
- Size
- 5.2 KB